Alzheimer'
Conditions
Interventions
To administer the test food containing 0.5 mg of plasmalogen twice a day for 6 months and observe the changes of MMSE and other medical indices
To administer the placebo food twice a day for 6 months
Sponsors
Plasmalogens Research Society
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Informed consents are obtained in writing from patients or one of their caretakers 2. Those who regularly go to hospitals conducting this study and are 60 or more but less than 85 years old (regardless of gender) 3.Those whom the responsible doctor have diagnosed as mild Alzheimer's disease or mild cognitive impairment based on DSM5 4.Those who have showed 20 or more and 27 or less in the score of Mini Mental State Examination 5.Those who have showed 5 or less in the score of geriatric Depression scale-short Version 6. Those who have stayed on the same medications since 3 months before the study until it's termination if they have been prescribed 7. Those who are judged as suitable for participation in this study by responsible doctors at the beginning of the study
Exclusion criteria
Exclusion criteria: 1. Those who have scallop allergy 2. Those who are judged as not suitable for participation in this study by responsible doctors at the beginning of the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cognitive function test (Mini Mental State Examination) | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Cognitive function test (Wechsler Memory Scale-Revised) 2.Blood Plasmalogen 3.Geriatric Depression Scale-Short Version | — |
Countries
Japan
Contacts
Public ContactChikako Wakana
Plasmalogens Research Society General Manager
Outcome results
None listed